Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Ischemic Heart Disease

  Free Subscription


Articles published in Clin Cardiol

Retrieve available abstracts of 170 articles:
HTML format



Single Articles


    March 2024
  1. LIU L, Du X, Wei X, Dong W, et al
    The combination of high-frequency QRS and ST-segment alterations during exercise stress tests enhanced the diagnostic efficacy for coronary artery disease.
    Clin Cardiol. 2024;47:e24254.
    PubMed     Abstract available


  2. PAN Y, Wu TT, Deng CJ, Yang Y, et al
    Smoking and outcomes following personalized antiplatelet therapy in chronic coronary syndrome patients: A substudy from the randomized PATH-PCI trial.
    Clin Cardiol. 2024;47:e24214.
    PubMed     Abstract available


  3. LEI H, Zhu L, Zhang X
    Knowledge, attitude, and practice toward postoperative self-management among patients after percutaneous coronary intervention: A structural equation modeling analysis.
    Clin Cardiol. 2024;47:e24232.
    PubMed     Abstract available


    February 2024
  4. HAQ A, Walser-Kuntz E, Gamam A, Albers A, et al
    Clinical characteristics and statin eligibility of patients under 50 with ST-elevation myocardial infarction.
    Clin Cardiol. 2024;47:e24231.
    PubMed     Abstract available


  5. KLONER RA, Stanek E, Desai K, Crowe CL, et al
    The association of tadalafil exposure with lower rates of major adverse cardiovascular events and mortality in a general population of men with erectile dysfunction.
    Clin Cardiol. 2024;47:e24234.
    PubMed     Abstract available


  6. ERGUI I, Salama J, Hooda U, Ebner B, et al
    In-hospital outcomes in unhoused patients with cardiogenic shock in the United States: Insights from The National Inpatient Sample 2011-2019.
    Clin Cardiol. 2024;47:e24235.
    PubMed     Abstract available


  7. KAWADA T
    Comment on "Association of kidney disease index with all-cause and cardiovascular mortality among individuals with hypertension".
    Clin Cardiol. 2024;47:e24242.
    PubMed    


  8. XIONG C, Yu Q, Gao F, Liu S, et al
    Prognostic significance of IL-18 in acute coronary syndrome patients.
    Clin Cardiol. 2024;47:e24229.
    PubMed     Abstract available


  9. LIU J, Zhao L, Zhang Y, Wang L, et al
    A higher non-HDL-C/HDL-C ratio was associated with an increased risk of progression of nonculprit coronary lesion in patients with acute coronary syndrome undergoing percutaneous coronary intervention.
    Clin Cardiol. 2024;47:e24243.
    PubMed     Abstract available


  10. YANG Y, Dong YZ, Hou AX, Liu P, et al
    Establishment and validation of a prediction model for nonrecovery of left ventricular ejection fraction in acute myocardial infarction patients combined with decreased left ventricular ejection fraction.
    Clin Cardiol. 2024;47:e24212.
    PubMed     Abstract available


  11. WANG L, Huang S, Zhou Q, Dou L, et al
    The predictive value of laboratory parameters for no-reflow phenomenon in patients with ST-elevation myocardial infarction following primary percutaneous coronary intervention: A meta-analysis.
    Clin Cardiol. 2024;47:e24238.
    PubMed     Abstract available


  12. SUPPLES MW, Snavely AC, O'Neill JC, Ashburn NP, et al
    Sex and race differences in the performance of the European Society of Cardiology 0/1-h algorithm with high-sensitivity troponin T.
    Clin Cardiol. 2024;47:e24199.
    PubMed     Abstract available


  13. ZHAO Z, Fu Y, Lian H, Liu Y, et al
    Correlation between the serum FABP4, ANGPTL3, and ANGPTL4 levels and coronary artery disease.
    Clin Cardiol. 2024;47:e24246.
    PubMed     Abstract available


  14. ZENG JL, Chen JH, Zhang LW, Chen LC, et al
    Lactate dehydrogenase-to-albumin ratio: A superior inflammatory marker for predicting contrast-associated acute kidney injury after percutaneous coronary intervention.
    Clin Cardiol. 2024;47:e24219.
    PubMed     Abstract available


  15. KIM JH, Yoon YC, Kim YH, Park JI, et al
    Cardiovascular outcomes between dapagliflozin versus empagliflozin in patients with diabetes mellitus.
    Clin Cardiol. 2024;47:e24248.
    PubMed     Abstract available


    January 2024
  16. YEH JT, Huang CC, Leu HB, Yin WH, et al
    Fatty acid-binding protein-3 and renal function decline in patients with chronic coronary syndrome.
    Clin Cardiol. 2024;47:e24210.
    PubMed     Abstract available


  17. SABET HR, Ahmadi M, Akrami M, Motamed M, et al
    Effects of flaxseed supplementation on weight loss, lipid profiles, glucose, and high-sensitivity C-reactive protein in patients with coronary artery disease: A systematic review and meta-analysis of randomized controlled trials.
    Clin Cardiol. 2024;47:e24211.
    PubMed     Abstract available


  18. ALLESCHER J, Sinnecker D, von Goeldel B, Barthel P, et al
    QRS fragmentation does not predict mortality in survivors of acute myocardial infarction.
    Clin Cardiol. 2024;47:e24218.
    PubMed     Abstract available


  19. YIN R, Ye Z, You H, Wu Y, et al
    Elevated uric acid/albumin ratio as a predictor of poor coronary collateral circulation development in patients with non-ST segment elevation myocardial infarction.
    Clin Cardiol. 2024;47:e24215.
    PubMed     Abstract available


  20. NORDLUND D, Lav T, Jablonowski R, Khoshnood A, et al
    Contractility, ventriculoarterial coupling, and stroke work after acute myocardial infarction using CMR-derived pressure-volume loop data.
    Clin Cardiol. 2024;47:e24216.
    PubMed     Abstract available


  21. MANSOURI MH, Mansouri P, Sadeghi M, Hashemi SM, et al
    Antianginal effects of empagliflozin in patients with type 2 diabetes and refractory angina; a randomized, double-blind placebo-controlled trial (EMPT-ANGINA Trial).
    Clin Cardiol. 2024;47:e24158.
    PubMed     Abstract available


  22. JIANG Z, Shao F, Hu J, Zhuang Q, et al
    Time-weighted blood pressure with cardiovascular risk among patients with or without diabetes.
    Clin Cardiol. 2024;47:e24213.
    PubMed     Abstract available


    December 2023
  23. WANG C, Liu S, Yang Y, Kamronbek R, et al
    Interleukin-4 and Interleukin-17 are associated with coronary artery disease.
    Clin Cardiol. 2023 Dec 25. doi: 10.1002/clc.24188.
    PubMed     Abstract available


  24. LI WJ, Xu HW
    The differences between patients with nonalcoholic fatty liver disease (NAFLD) and those without NAFLD, as well as predictors of functional coronary artery ischemia in patients with NAFLD.
    Clin Cardiol. 2023 Dec 18. doi: 10.1002/clc.24205.
    PubMed     Abstract available


    November 2023
  25. LI M, Wang Y, Li L, Wu W, et al
    Global myocardial work in coronary artery disease patients without regional wall motion abnormality: Correlation with Gensini-score.
    Clin Cardiol. 2023 Nov 28. doi: 10.1002/clc.24193.
    PubMed     Abstract available


  26. WANG H, Wu Q, Yang L, Chen L, et al
    Application of AMR in evaluating microvascular dysfunction after ST-elevation myocardial infarction.
    Clin Cardiol. 2023 Nov 24. doi: 10.1002/clc.24196.
    PubMed     Abstract available


  27. HUANG L, Wang A, Wu Z, Chen S, et al
    Life's essential 8 and risk of all-cause mortality in individuals with cardiovascular diseases: A prospective community-based study.
    Clin Cardiol. 2023 Nov 23. doi: 10.1002/clc.24119.
    PubMed     Abstract available


  28. LV H, Li X, Ren Z, Ma X, et al
    Intravascular lithotripsy: A novel option for severe calcification of coronary artery.
    Clin Cardiol. 2023 Nov 9. doi: 10.1002/clc.24186.
    PubMed     Abstract available


  29. GAVINA C, Seabra-Carvalho D, Aguiar C, Anastassopoulou A, et al
    Characterization and LDL-C management in a cohort of high and very high cardiovascular risk patients: The PORTRAIT-DYS study.
    Clin Cardiol. 2023 Nov 6. doi: 10.1002/clc.24183.
    PubMed     Abstract available


  30. WANG M, Hu Z, Miao L, Shi M, et al
    A systematic review of the applicability of emergency department assessment of chest pain score-accelerated diagnostic protocol for risk stratification of patients with chest pain.
    Clin Cardiol. 2023;46:1303-1309.
    PubMed     Abstract available


    October 2023
  31. PAN LH, Yan BY, Zhu J, Lu Q, et al
    Effects of using primary percutaneous coronary interventions on the incidence of new-onset atrial fibrillation following an acute myocardial infarction.
    Clin Cardiol. 2023 Oct 25. doi: 10.1002/clc.24167.
    PubMed     Abstract available


  32. LOUTATI R, Perel N, Bruoha S, Taha L, et al
    Troponin level at presentation as a prognostic factor among patients presenting with non-ST-segment elevation myocardial infarction.
    Clin Cardiol. 2023 Oct 19. doi: 10.1002/clc.24166.
    PubMed     Abstract available


  33. BEATTY C, Richardson KP, Tran PMH, Satter KB, et al
    Multiplex analysis of inflammatory proteins associated with risk of coronary artery disease in type-1 diabetes patients.
    Clin Cardiol. 2023 Oct 11. doi: 10.1002/clc.24143.
    PubMed     Abstract available


  34. FALLAHZADEH A, Mehraban S, Mahmoodi T, Sheikhy A, et al
    Risk factor profile and outcomes of premature acute coronary syndrome after percutaneous coronary intervention: A 1-year prospective design.
    Clin Cardiol. 2023 Oct 11. doi: 10.1002/clc.24170.
    PubMed     Abstract available


  35. ZHU L, Chen Z, Jiang H, Wang P, et al
    Association of red blood cell distribution width and hemoglobin-to-RDW ratio with contrast-associated acute kidney injury in patients undergoing coronary angiography: A retrospective study.
    Clin Cardiol. 2023 Oct 4. doi: 10.1002/clc.24163.
    PubMed     Abstract available


    September 2023
  36. DI GIACOMO D, Ranieri J, Guerra F, Cilli E, et al
    Cardiovascular risk and biopsychosocial interplay: Association among hypertension, anxiety, and emotional dysregulation-observational study in primary care setting for efficient self-care.
    Clin Cardiol. 2023 Sep 28. doi: 10.1002/clc.24152.
    PubMed     Abstract available


  37. ZHONG D, Cheng H
    Application of Mendelian randomization in the discovery of risk factors for coronary heart disease from 2009 to 2023: A bibliometric review.
    Clin Cardiol. 2023 Sep 19. doi: 10.1002/clc.24154.
    PubMed     Abstract available


  38. LI JQ, An Y, Wang T, Guo PX, et al
    Relationship between ideal cardiovascular health score and perioperative acute kidney injury: A case-control study.
    Clin Cardiol. 2023 Sep 19. doi: 10.1002/clc.24159.
    PubMed     Abstract available


  39. TOFIGHI S, Poorhosseini H, Jenab Y, Alidoosti M, et al
    Comparison of machine-learning models for the prediction of 1-year adverse outcomes of patients undergoing primary percutaneous coronary intervention for acute ST-elevation myocardial infarction.
    Clin Cardiol. 2023 Sep 18. doi: 10.1002/clc.24157.
    PubMed     Abstract available


  40. WIENEKE H, Voigt I
    Principles of artificial intelligence and its application in cardiovascular medicine.
    Clin Cardiol. 2023 Sep 18. doi: 10.1002/clc.24148.
    PubMed     Abstract available



  41. Correction to "Risk factors based vessel-specific prediction for stages of coronary artery disease using Bayesian quantile regression machine learning method: Results from the PARADIGM registry".
    Clin Cardiol. 2023 Sep 11. doi: 10.1002/clc.24150.
    PubMed    


  42. XU L, Pinxten W, Vandereyt F, Falter M, et al
    Motivational communication skills to improve motivation and adherence in cardiovascular disease prevention: A narrative review.
    Clin Cardiol. 2023 Sep 7. doi: 10.1002/clc.24128.
    PubMed     Abstract available


  43. XU H, Qiao S, Cui J, Yuan J, et al
    Drug-eluting stent and drug-coated balloon for the treatment of de novo diffuse coronary artery disease lesions: A retrospective case series study.
    Clin Cardiol. 2023 Sep 4. doi: 10.1002/clc.24140.
    PubMed     Abstract available


  44. FAN H, Zhao J, Mao S, Wang Y, et al
    Circulating Th17/Treg as a promising biomarker for patients with rheumatoid arthritis in indicating comorbidity with atherosclerotic cardiovascular disease.
    Clin Cardiol. 2023 Sep 4. doi: 10.1002/clc.24065.
    PubMed     Abstract available


  45. LI F, Wang S, Wang Y, Wei C, et al
    Long-term safety of ultrathin bioabsorbable-polymer sirolimus-eluting stents versus thin durable-polymer drug-eluting stents in acute coronary syndrome: A systematic review and meta-analysis.
    Clin Cardiol. 2023 Sep 3. doi: 10.1002/clc.24139.
    PubMed     Abstract available


    August 2023
  46. SONG L, Li Y, Nie S, Feng Z, et al
    Using machine learning to predict adverse events in acute coronary syndrome: A retrospective study.
    Clin Cardiol. 2023 Aug 31. doi: 10.1002/clc.24127.
    PubMed     Abstract available


  47. FANG S, Chen Y, Gao Q, Wei Q, et al
    Association of kidney disease index with all-cause and cardiovascular mortality among individuals with hypertension.
    Clin Cardiol. 2023 Aug 21. doi: 10.1002/clc.24131.
    PubMed     Abstract available


  48. WANG L, Liu J, Fang H, Wang X, et al
    Factors associated with participation in cardiac rehabilitation in patients with acute myocardial infarction: A systematic review and meta-analysis.
    Clin Cardiol. 2023 Aug 18. doi: 10.1002/clc.24130.
    PubMed     Abstract available


  49. MA X, Zhang H, Tian Y, Wang Y, et al
    Mediating effect of depression on the association between cardiovascular disease and the risk of all-cause mortality: NHANES in 2005-2018.
    Clin Cardiol. 2023 Aug 18. doi: 10.1002/clc.24103.
    PubMed     Abstract available


  50. DANG W, Cao N, Zhang Y, Li W, et al
    Association among beta2-adrenergic receptor autoantibodies and proximal left anterior descending artery lesions in patients with initial ST-segment elevation myocardial infarction.
    Clin Cardiol. 2023 Aug 17. doi: 10.1002/clc.24129.
    PubMed     Abstract available


  51. LI F, Zhang Y, Pan L, Chen H, et al
    Effects of dietary patterns on the all-cause mortality and cardiovascular disease mortality in patients with hypertension: A cohort study based on the NHANES database.
    Clin Cardiol. 2023 Aug 16. doi: 10.1002/clc.24118.
    PubMed     Abstract available


  52. CHEN J, Li J, Yue YH, Liu Y, et al
    Nomogram for predicting coronary artery lesions in patients with Kawasaki disease.
    Clin Cardiol. 2023 Aug 4. doi: 10.1002/clc.24113.
    PubMed     Abstract available


    July 2023
  53. LI Y, Zhang Y, Xiao K, Si J, et al
    The incidence of subclinical atherosclerosis in subjects with low and moderate cardiovascular risk.
    Clin Cardiol. 2023 Jul 31. doi: 10.1002/clc.24087.
    PubMed     Abstract available


  54. TABAGHI S, Sheibani M, Khaheshi I, Miri R, et al
    Associations between Short-Term Exposure to Fine Particulate Matter and Acute Myocardial Infarction: A Case-Crossover Study.
    Clin Cardiol. 2023 Jul 28. doi: 10.1002/clc.24111.
    PubMed     Abstract available



  55. Correction to "Atherosclerosis imaging quantitative computed tomography (AI-QCT) to guide referral to invasive coronary angiography in the randomized controlled CONSERVE trial".
    Clin Cardiol. 2023 Jul 27. doi: 10.1002/clc.24083.
    PubMed    


  56. LEE W, Kang SH, Kim SH, Lee SY, et al
    Impact of dementia and drug compliance on patients with acute myocardial infarction.
    Clin Cardiol. 2023 Jul 24. doi: 10.1002/clc.24091.
    PubMed     Abstract available


  57. SENTHIL KUMARAN S, Del Cid Fratti J, Desai A, Garg R, et al
    Racial disparities in women with ST elevation myocardial infarction: A National Inpatient Sample review of baseline characteristics, co-morbidities, and outcomes in women with STEMI.
    Clin Cardiol. 2023 Jul 13. doi: 10.1002/clc.24068.
    PubMed     Abstract available


  58. ZEPPILLI P, Bianco M, Gervasi SF, Cammarano M, et al
    Congenital coronary artery anomalies in sports medicine. Why to know them.
    Clin Cardiol. 2023 Jul 11. doi: 10.1002/clc.24084.
    PubMed     Abstract available


  59. SUN Y, Ren J, Wang W, Wang C, et al
    Predictive value of CHA(2) DS(2) -VASc score for in-hospital prognosis of patients with acute ST-segment elevation myocardial infarction undergoing primary PCI.
    Clin Cardiol. 2023 Jul 10. doi: 10.1002/clc.24071.
    PubMed     Abstract available


    June 2023
  60. VAN STEENBERGEN GJ, Demandt JPA, Schulz DN, Tonino PA, et al
    Direct admission versus interhospital transfer for revascularisation in non-ST-segment elevation myocardial infarction.
    Clin Cardiol. 2023 Jun 21. doi: 10.1002/clc.24060.
    PubMed     Abstract available


  61. NOBAH AMA, Abuheit EMI, Jian L, Wang X, et al
    Clinical assessment of VSR site and size and its relation to the severity of heart failure in post-myocardial infarction ventricular septal rupture patients.
    Clin Cardiol. 2023 Jun 20. doi: 10.1002/clc.24062.
    PubMed     Abstract available


  62. KATAOKA N, Imamura T
    Impact of implantable cardioverter defibrillator on survival in patients with non-ischemic dilated cardiomyopathy.
    Clin Cardiol. 2023 Jun 12. doi: 10.1002/clc.24032.
    PubMed    


  63. HUANG H, Leung KSK, Garg T, Mazzoleni A, et al
    Barriers and shortcomings in access to cardiovascular management and prevention for familial hypercholesterolemia during the COVID-19 pandemic.
    Clin Cardiol. 2023 Jun 1. doi: 10.1002/clc.24059.
    PubMed     Abstract available


    May 2023
  64. ROMANO S, Minardi S, Patrizi G, Palama Z, et al
    Sport in ischemic heart disease: Focus on primary and secondary prevention.
    Clin Cardiol. 2023 May 28. doi: 10.1002/clc.24052.
    PubMed     Abstract available


  65. MU X, Qiu M, Li Y, Li Z, et al
    N-terminal pro-B-type natriuretic peptide improves the predictive value of CHA(2) DS(2) -VASc risk score for long-term cardiovascular events in acute coronary syndrome patients with atrial fibrillation.
    Clin Cardiol. 2023 May 22. doi: 10.1002/clc.24037.
    PubMed     Abstract available


  66. GONG X, Hua R, Bai J, Wu T, et al
    Rationale and design of the optimal antithrombotic treatment for acute coronary syndrome patients with concomitant atrial fibrillation and implanted with new-generation drug-eluting stent: OPtimal management of anTIthroMbotic Agents (OPTIMA)-4 trial.
    Clin Cardiol. 2023 May 16. doi: 10.1002/clc.24025.
    PubMed     Abstract available


  67. CHEN T, Liu Y, Zhang J, Sun Z, et al
    Percutaneous closure of ventricular septal rupture after myocardial infarction: A retrospective study of 81 cases.
    Clin Cardiol. 2023 May 15. doi: 10.1002/clc.24027.
    PubMed     Abstract available


    April 2023
  68. LIU R, Liu H, Yuan D, Chen Y, et al
    For patients with prior coronary artery bypass grafting and recurrent myocardial ischemia, percutaneous coronary intervention on bypass graft or native coronary artery?-A 5-year follow-up cohort study.
    Clin Cardiol. 2023 Apr 28. doi: 10.1002/clc.24021.
    PubMed     Abstract available


  69. WANG H, Li L, Ma Y
    Platelet-to-lymphocyte ratio a potential prognosticator in acute myocardial infarction: A prospective longitudinal study.
    Clin Cardiol. 2023 Apr 14. doi: 10.1002/clc.24002.
    PubMed     Abstract available


  70. WANG B, Liu X, Hao W, Fan J, et al
    Comorbid obstructive sleep apnea is associated with adverse cardiovascular outcomes in female patients with acute coronary syndrome complicating metabolic syndrome.
    Clin Cardiol. 2023 Apr 14. doi: 10.1002/clc.24020.
    PubMed     Abstract available


  71. WANG Y, Sun J, Sun K, Li L, et al
    ECG-based cardiodynamicsgram can reflect anomalous functional information in coronary artery disease.
    Clin Cardiol. 2023 Apr 6. doi: 10.1002/clc.24019.
    PubMed     Abstract available


  72. VERVAAT FE, van der Gaag A, Smetsers C, Barneveld PC, et al
    Design and rationale of the efficacy of spinal cord stimulation in patients with refractory angina pectoris (SCRAP) trial.
    Clin Cardiol. 2023 Apr 4. doi: 10.1002/clc.24016.
    PubMed     Abstract available


  73. CATAPANO AL, De Caterina R, Jukema JW, Klempfner R, et al
    Addressing current challenges in optimization of lipid management following an ACS event: Outcomes of the ACS EuroPath III initiative.
    Clin Cardiol. 2023;46:407-415.
    PubMed     Abstract available


    March 2023
  74. KHALAJI A, Ajam A, Sheikhy A, Behnoush AH, et al
    Mortality across the spectrum of hemoglobin level in patients undergoing surgical coronary revascularization.
    Clin Cardiol. 2023 Mar 23. doi: 10.1002/clc.24004.
    PubMed     Abstract available


  75. ZHANG C, Zeng S, Ji W, Li Z, et al
    Synergistic role of circulating CD14++CD16+ monocytes and fibrinogen in predicting the cardiovascular events after myocardial infarction.
    Clin Cardiol. 2023 Mar 22. doi: 10.1002/clc.24005.
    PubMed     Abstract available


  76. YI C, Junyi G, Fengju L, Qing Z, et al
    Association between lipoprotein(a) and peripheral arterial disease in coronary artery bypass grafting patients.
    Clin Cardiol. 2023 Mar 10. doi: 10.1002/clc.24003.
    PubMed     Abstract available


  77. WADA S, Iwanaga Y, Nakai M, Nakao YM, et al
    Combination of coronary CT angiography, FFR(CT) , and risk factors in the prediction of major adverse cardiovascular events in patients suspected CAD.
    Clin Cardiol. 2023 Mar 1. doi: 10.1002/clc.23989.
    PubMed     Abstract available


  78. WANG B, Gao Y, Zhao Y, Xu C, et al
    The spectrum of angiography-derived IMR according to morphological and physiological coronary stenosis in patients with suspected myocardial ischemia.
    Clin Cardiol. 2023 Mar 1. doi: 10.1002/clc.23999.
    PubMed     Abstract available


    February 2023
  79. KIM Y, Choi AD, Telluri A, Lipkin I, et al
    Atherosclerosis Imaging Quantitative Computed Tomography (AI-QCT) to guide referral to invasive coronary angiography in the randomized controlled CONSERVE trial.
    Clin Cardiol. 2023 Feb 27. doi: 10.1002/clc.23995.
    PubMed     Abstract available


  80. DEAN YE, Shebl MA, Rouzan SS, Bamousa BAA, et al
    Association between insomnia and the incidence of myocardial infarction: A systematic review and meta-analysis.
    Clin Cardiol. 2023 Feb 25. doi: 10.1002/clc.23984.
    PubMed     Abstract available


  81. LIU ES, Yang TH, Tai TH, Chiang CH, et al
    Long-term outcomes after stent implantation in very small vessel coronary artery disease.
    Clin Cardiol. 2023 Feb 23. doi: 10.1002/clc.24000.
    PubMed     Abstract available


  82. YOUN YJ, Jeon HS, Kim YI, Lee JH, et al
    Impact of the ultra-long 48 mm drug-eluting stent on procedural and clinical outcomes in patients with diffuse long coronary artery disease.
    Clin Cardiol. 2023 Feb 20. doi: 10.1002/clc.23997.
    PubMed     Abstract available


  83. CHEN W, Lin G, Dai C, Xu K, et al
    Predictive value of serum iron on heart failure in patients with acute ST-segment elevation myocardial infarction.
    Clin Cardiol. 2023 Feb 13. doi: 10.1002/clc.23990.
    PubMed     Abstract available


  84. DESAI R, Fadah K, Srikanth S, Neha NFN, et al
    Fibrinogen-albumin ratio predicting major adverse cardiovascular outcomes post-percutaneous coronary intervention: A systematic review and exploratory meta-analysis.
    Clin Cardiol. 2023 Feb 1. doi: 10.1002/clc.23981.
    PubMed    


  85. JUSTO FA, de Deus Herrera B, Soares PR, Scudeler TL, et al
    Plato's allegory of the cave and the paradigm of complete revascularization in STEMI.
    Clin Cardiol. 2023;46:232-233.
    PubMed    


    January 2023
  86. PARK HB, Lee J, Hong Y, Byungchang S, et al
    Risk factors based vessel-specific prediction for stages of coronary artery disease using Bayesian quantile regression machine learning method: Results from the PARADIGM registry.
    Clin Cardiol. 2023 Jan 24. doi: 10.1002/clc.23964.
    PubMed     Abstract available


  87. FREEDMAN BL, Berg DD, Scirica BM, Bohula EA, et al
    Response to Mei et al. regarding the incidence and predictors of hospitalization for heart failure among patients with stable atherosclerosis in the TRA 2 degrees P-TIMI 50 trial.
    Clin Cardiol. 2023 Jan 24. doi: 10.1002/clc.23972.
    PubMed    


  88. KODESH A, Bental T, Vaknin-Assa H, Talmor-Barkan Y, et al
    The independent impact of dementia in patients undergoing percutaneous coronary intervention for acute myocardial infarction.
    Clin Cardiol. 2023 Jan 12. doi: 10.1002/clc.23967.
    PubMed     Abstract available


  89. BEHNOUSH AH, Khalaji A, Rezaee M, Momtahen S, et al
    Machine learning-based prediction of 1-year mortality in hypertensive patients undergoing coronary revascularization surgery.
    Clin Cardiol. 2023 Jan 1. doi: 10.1002/clc.23963.
    PubMed     Abstract available


  90. AL-KASSOU B, Veulemans V, Shamekhi J, Maier O, et al
    Optimal protamine-to-heparin dosing ratio for the prevention of bleeding complications in patients undergoing TAVR-A multicenter experience.
    Clin Cardiol. 2023;46:67-75.
    PubMed     Abstract available


    December 2022
  91. MOHAMMED AA, Zhang H, Abdu FA, Liu L, et al
    Effect of nonobstructive coronary stenosis on coronary microvascular dysfunction and long-term outcomes in patients with INOCA.
    Clin Cardiol. 2022 Dec 25. doi: 10.1002/clc.23962.
    PubMed     Abstract available


  92. LIN L, Huang J, Liu Z, Chen P, et al
    Associations of siesta and total sleep duration with hypertension or cardiovascular diseases in middle-aged and older adults.
    Clin Cardiol. 2022 Dec 12. doi: 10.1002/clc.23954.
    PubMed     Abstract available


  93. LUO F, Luo JY, Liu F, Qiu YJ, et al
    Coronary artery calcium and cystatin C for risk stratification of MACCEs and all-cause death in symptomatic patients.
    Clin Cardiol. 2022 Dec 9. doi: 10.1002/clc.23959.
    PubMed     Abstract available


  94. LI R, Shen L, Ma W, Yan B, et al
    Use of machine learning models to predict in-hospital mortality in patients with acute coronary syndrome.
    Clin Cardiol. 2022 Dec 7. doi: 10.1002/clc.23957.
    PubMed     Abstract available


  95. BONACA MP, Szarek M, Debus ES, Nehler MR, et al
    Efficacy and safety of rivaroxaban versus placebo after lower extremity bypass surgery: A post hoc analysis of a "CASPAR like" outcome from VOYAGER PAD.
    Clin Cardiol. 2022;45:1143-1146.
    PubMed     Abstract available


  96. SAADA M, Kobo O, Polad J, Halabi M, et al
    Prognosis of PCI in AMI setting in the elderly population: Outcomes from the multicenter prospective e-ULTIMASTER registry.
    Clin Cardiol. 2022;45:1211-1219.
    PubMed     Abstract available


    November 2022
  97. BROCKMEYER M, Wies E, Joerges J, Sommer J, et al
    Knowledge of HbA1c and LDL-C treatment goals, subjective level of disease-related information and information needs in patients with atherosclerotic cardiovascular disease.
    Clin Cardiol. 2022 Nov 30. doi: 10.1002/clc.23948.
    PubMed     Abstract available


  98. LIMPIJANKIT T, Jongjirasiri S, Meemook K, Unwanatham N, et al
    Predictive values of coronary artery calcium and arterial stiffness for long-term cardiovascular events in patients with stable coronary artery disease.
    Clin Cardiol. 2022 Nov 29. doi: 10.1002/clc.23955.
    PubMed     Abstract available


  99. GAO Y, Guo Y, Dong J, Liu Y, et al
    Differences in the prevalence of cardiovascular and metabolic diseases coinciding with clinical subtypes of obstructive sleep apnea.
    Clin Cardiol. 2022 Nov 20. doi: 10.1002/clc.23941.
    PubMed     Abstract available


  100. BAGAI A, Ali FM, Gregson J, Alexander KP, et al
    Multimorbidity, functional impairment, and mortality in older patients stable after prior acute myocardial infarction: Insights from the TIGRIS registry.
    Clin Cardiol. 2022 Nov 1. doi: 10.1002/clc.23915.
    PubMed     Abstract available


  101. COTTER B, Raisinghani A, DeMaria AN
    Established and emerging roles for ultrasound enhancing agents (contrast echocardiography).
    Clin Cardiol. 2022;45:1114-1122.
    PubMed     Abstract available


    October 2022
  102. DESAI NR, Farbaniec M, Karalis DG
    Nonadherence to lipid-lowering therapy and strategies to improve adherence in patients with atherosclerotic cardiovascular disease.
    Clin Cardiol. 2022 Oct 20. doi: 10.1002/clc.23935.
    PubMed     Abstract available


  103. CHENG Q, Zhou D, Wang J, Nie Z, et al
    Sex-specific risk factors of carotid atherosclerosis progression in a high-risk population of cardiovascular disease.
    Clin Cardiol. 2022 Oct 13. doi: 10.1002/clc.23931.
    PubMed     Abstract available


  104. MORTENSEN MB, Sand NP, Busk M, Jensen JM, et al
    Influence of intensive lipid-lowering on CT derived fractional flow reserve in patients with stable chest pain: Rationale and design of the FLOWPROMOTE study.
    Clin Cardiol. 2022;45:986-994.
    PubMed     Abstract available


    September 2022
  105. YU Q, Guo D, Peng J, Wu Q, et al
    Prevalence and adverse outcomes of frailty in older patients with acute myocardial infarction after percutaneous coronary interventions: A systematic review and meta-analysis.
    Clin Cardiol. 2022 Sep 28. doi: 10.1002/clc.23929.
    PubMed     Abstract available


  106. IVEY SL, Hanley HR, Taylor C, Stock E, et al
    Early identification and treatment of women's cardiovascular risk factors prevents cardiovascular disease, saves lives, and protects future generations: Policy recommendations and take action plan utilizing policy levers.
    Clin Cardiol. 2022 Sep 20. doi: 10.1002/clc.23921.
    PubMed     Abstract available


  107. SHAIK A, Kosiborod M, de Lemos JA, Gao Q, et al
    Use of lipid-lowering therapies in patients with chronic kidney disease and atherosclerotic cardiovascular disease: 2-year results from Getting to an imprOved Understanding of Low-Density lipoprotein cholesterol and dyslipidemia management (GOULD).
    Clin Cardiol. 2022 Sep 19. doi: 10.1002/clc.23923.
    PubMed     Abstract available


  108. NAZER RI, Albarrati AM
    The brain-before-heart strategy for coronary artery bypass grafting in the severely atherosclerotic aorta: A single-institution experience.
    Clin Cardiol. 2022 Sep 19. doi: 10.1002/clc.23913.
    PubMed     Abstract available


  109. CHEN C, Li X, Su Y, You Z, et al
    Adherence with cardiovascular medications and the outcomes in patients with coronary arterial disease: "Real-world" evidence.
    Clin Cardiol. 2022 Sep 18. doi: 10.1002/clc.23898.
    PubMed     Abstract available


  110. MANIAR Y, Blumenthal RS, Alfaddagh A
    The role of coronary artery calcium in allocating pharmacotherapy for primary prevention of cardiovascular disease: The ABCs of CAC.
    Clin Cardiol. 2022 Sep 10. doi: 10.1002/clc.23918.
    PubMed     Abstract available


  111. YI M, Cao Q, Tang WH, Liu Q, et al
    Day-to-day fasting plasma glucose variability on the short-term prognosis of ST-segment elevation myocardial infarction: A retrospective cohort study.
    Clin Cardiol. 2022 Sep 7. doi: 10.1002/clc.23899.
    PubMed     Abstract available


  112. YAO H, Guo Q, Cheng Y, Zhu T, et al
    Predictors and morphological properties of culprit healed plaques in patients with angina pectoris.
    Clin Cardiol. 2022 Sep 7. doi: 10.1002/clc.23896.
    PubMed     Abstract available


  113. VALENTINE CM, Chazal RA
    Essential nonclinical competencies for cardiovascular specialists imperatives for training.
    Clin Cardiol. 2022 Sep 7. doi: 10.1002/clc.23914.
    PubMed     Abstract available


  114. BRACEWELL NJ, Plasschaert J, Conti CR, Keeley EC, et al
    Cardiac rehabilitation: Effective yet underutilized in patients with cardiovascular disease.
    Clin Cardiol. 2022 Sep 2. doi: 10.1002/clc.23911.
    PubMed     Abstract available


  115. YANG Y, Hong Y, Yang W, Zheng Z, et al
    Association of lipoprotein(a) with aortic dissection.
    Clin Cardiol. 2022;45:908-912.
    PubMed     Abstract available


    August 2022
  116. SHARMA P, Shah K, Loomba J, Patel A, et al
    The impact of COVID-19 on clinical outcomes among acute myocardial infarction patients undergoing early invasive treatment strategy.
    Clin Cardiol. 2022 Aug 30. doi: 10.1002/clc.23908.
    PubMed     Abstract available


  117. MOTAWEA KR, Gaber H, Singh RB, Swed S, et al
    Effect of early metoprolol before PCI in ST-segment elevation myocardial infarction on infarct size and left ventricular ejection fraction. A systematic review and meta-analysis of clinical trials.
    Clin Cardiol. 2022 Aug 30. doi: 10.1002/clc.23894.
    PubMed     Abstract available


    July 2022
  118. NAAMI R, Naami E, Omari T, Lowi SG, et al
    Cardiac rehabilitation performance predicts 1-year major adverse cardiovascular events.
    Clin Cardiol. 2022 Jul 29. doi: 10.1002/clc.23890.
    PubMed     Abstract available


  119. FREEDMAN BL, Berg DD, Scirica BM, Bohula EA, et al
    Epidemiology of heart failure hospitalization in patients with stable atherothrombotic disease: Insights from the TRA 2 degrees P-TIMI 50 trial.
    Clin Cardiol. 2022 Jul 19. doi: 10.1002/clc.23843.
    PubMed     Abstract available


  120. ZDANYTE M, Martus P, Nestele J, Bild A, et al
    Risk assessment in COVID-19: Prognostic importance of cardiovascular parameters.
    Clin Cardiol. 2022 Jul 5. doi: 10.1002/clc.23883.
    PubMed     Abstract available


    June 2022
  121. WU C, Bu R, Wang Y, Xu C, et al
    Rehabilitation effects of circuit resistance training in coronary heart disease patients: A systematic review and meta-analysis.
    Clin Cardiol. 2022 Jun 27. doi: 10.1002/clc.23855.
    PubMed     Abstract available


  122. LIMPIJANKIT T, Chandavimol M, Srimahachota S, Kanoksilp A, et al
    Dose-dependent effect of impaired renal function on all-cause mortality in patients following percutaneous coronary intervention.
    Clin Cardiol. 2022 Jun 27. doi: 10.1002/clc.23877.
    PubMed     Abstract available


  123. DE LUCA L, Calabro P, Chirillo F, Rolfo C, et al
    Use of cangrelor in patients with acute coronary syndromes undergoing percutaneous coronary intervention: Study design and interim analysis of the ARCANGELO study.
    Clin Cardiol. 2022 Jun 22. doi: 10.1002/clc.23878.
    PubMed     Abstract available


  124. SCIRICA BM, Im K, Murphy SA, Kuder JF, et al
    Re-adjudication of the Trial Evaluating Cardiovascular Outcomes with Sitagliptin (TECOS) with study-level meta-analysis of hospitalization for heart failure from cardiovascular outcomes trials with dipeptidyl peptidase-4 (DPP-4) inhibitors.
    Clin Cardiol. 2022 Jun 17. doi: 10.1002/clc.23844.
    PubMed     Abstract available


  125. WON KB, Park HB, Heo R, Lee BK, et al
    Longitudinal quantitative assessment of coronary atherosclerosis related to normal systolic blood pressure maintenance in the absence of established cardiovascular disease.
    Clin Cardiol. 2022 Jun 8. doi: 10.1002/clc.23870.
    PubMed     Abstract available


  126. SCOTT C, Lateef SS, Hong CG, Dey AK, et al
    Inflammation, coronary plaque progression, and statin use: A secondary analysis of the Risk Stratification with Image Guidance of HMG CoA Reductase Inhibitor Therapy (RIGHT) study.
    Clin Cardiol. 2022;45:622-628.
    PubMed     Abstract available


  127. MIYATA K, Asano T, Saito A, Abe K, et al
    Heart Team risk assessment with angiography-derived fractional flow reserve determining the optimal revascularization strategy in patients with multivessel disease: Trial design and rationale for the DECISION QFR randomized trial.
    Clin Cardiol. 2022;45:605-613.
    PubMed     Abstract available


    May 2022
  128. GAO L, Wang B, Cheng R
    Reply to comment on "Cardiovascular safety of febuxostat compared to allopurinol for the treatment of gout: A systematic and meta-analysis".
    Clin Cardiol. 2022 May 30. doi: 10.1002/clc.23852.
    PubMed    


  129. DENG JH, Zhang JX
    Comment on: Cardiovascular safety of febuxostat compared to allopurinol for the treatment of gout: A systematic and meta-analysis.
    Clin Cardiol. 2022 May 30. doi: 10.1002/clc.23851.
    PubMed    


  130. YOU W, Zhou Y, Wu Z, Meng P, et al
    Post-PCI quantitative flow ratio predicts 3-year outcome after rotational atherectomy in patients with heavily calcified lesions.
    Clin Cardiol. 2022;45:558-566.
    PubMed     Abstract available


    April 2022
  131. MOTAMED N, Ajdarkosh H, Karbalaie Niya MH, Panahi M, et al
    Scoring systems of metabolic syndrome and prediction of cardiovascular events: A population based cohort study.
    Clin Cardiol. 2022 Apr 14. doi: 10.1002/clc.23827.
    PubMed     Abstract available


    March 2022
  132. MA R, Gao J, Mao S, Wang Z, et al
    Association between heart rate and cardiovascular death in patients with coronary heart disease: A NHANES-based cohort study.
    Clin Cardiol. 2022 Mar 30. doi: 10.1002/clc.23818.
    PubMed     Abstract available


  133. STOHR R, Dirrichs T, Kneizeh K, Reinartz S, et al
    Influence of rivaroxaban compared to vitamin K antagonist treatment upon development of cardiovascular calcification in patients with atrial fibrillation and/or pulmonary embolism.
    Clin Cardiol. 2022 Mar 25. doi: 10.1002/clc.23819.
    PubMed     Abstract available


  134. SUN M, Xing Y, Guo Y, Cao X, et al
    Left atrial reservoir strain is an outstanding predictor of adverse cardiovascular outcomes in patients undergoing maintenance hemodialysis: Assessment via three-dimensional speckle tracking echocardiography.
    Clin Cardiol. 2022 Mar 21. doi: 10.1002/clc.23815.
    PubMed     Abstract available


  135. HOU J, Sun Y, Zhang L, Wang W, et al
    Assessing left atrial function in patients with atrial fibrillation and valvular heart disease using cardiovascular magnetic resonance imaging.
    Clin Cardiol. 2022 Mar 15. doi: 10.1002/clc.23811.
    PubMed     Abstract available


  136. TOPPILA I, Ukkola-Vuoti L, Perttila J, Tornwall O, et al
    Cardiovascular event rate and death in high-risk secondary prevention patient cohort in Finland: A registry study.
    Clin Cardiol. 2022 Mar 15. doi: 10.1002/clc.23814.
    PubMed     Abstract available


  137. SUN L, Zhou M, Ji Y, Wang X, et al
    Off-pump versus on-pump coronary artery bypass grafting for octogenarians: A meta-analysis involving 146 372 patients.
    Clin Cardiol. 2022 Mar 10. doi: 10.1002/clc.23794.
    PubMed     Abstract available


  138. LUPU L, Taha L, Banai A, Shmueli H, et al
    Immediate and early percutaneous coronary intervention in very high-risk and high-risk non-ST segment elevation myocardial infarction patients.
    Clin Cardiol. 2022 Mar 9. doi: 10.1002/clc.23781.
    PubMed     Abstract available


  139. STEHLI J, Dinh D, Dagan M, Dick R, et al
    Sex differences in treatment and outcomes of patients with in-hospital ST-elevation myocardial infarction.
    Clin Cardiol. 2022 Mar 7. doi: 10.1002/clc.23797.
    PubMed     Abstract available


  140. XUE L, Yang YC, Zhao Q, Zhao ZH, et al
    The spectrum and prevalence of arrhythmia in different clinical pulmonary hypertension groups in Chinese population.
    Clin Cardiol. 2022 Mar 7. doi: 10.1002/clc.23803.
    PubMed     Abstract available


  141. WANG G, Zhao N, Zhong S, Wang H, et al
    Association of early repolarization pattern and ventricular fibrillation in patients with vasospastic angina: A systematic review and meta-analysis.
    Clin Cardiol. 2022 Mar 7. doi: 10.1002/clc.23804.
    PubMed     Abstract available


  142. WEN XS, Luo R, Liu J, Liu ZQ, et al
    The duration of beta-blocker therapy and outcomes in patients without heart failure or left ventricular systolic dysfunction after acute myocardial infarction: A multicenter prospective cohort study.
    Clin Cardiol. 2022 Mar 4. doi: 10.1002/clc.23807.
    PubMed     Abstract available


    February 2022
  143. LEE P, Brennan A, Dinh D, Stub D, et al
    The cost-effectiveness of radial access percutaneous coronary intervention: A propensity-score matched analysis of Victorian data.
    Clin Cardiol. 2022 Feb 22. doi: 10.1002/clc.23798.
    PubMed     Abstract available


  144. KNOERY C, McEwan KA, Manktelow M, Watt J, et al
    Using latent class analysis to identify clinical features of patients with occlusive myocardial infarction: Preangiogram prediction remains difficult.
    Clin Cardiol. 2022 Feb 8. doi: 10.1002/clc.23755.
    PubMed     Abstract available


  145. VRSALOVIC M, Vrsalovic Presecki A, Aboyans V
    Cardiac troponins predict mortality and cardiovascular outcomes in patients with peripheral artery disease: A systematic review and meta-analysis of adjusted observational studies.
    Clin Cardiol. 2022 Feb 7. doi: 10.1002/clc.23776.
    PubMed     Abstract available


  146. ZHAO Y, Zhou P, Gao W, Zhong H, et al
    Cilostazol combined with P2Y12 receptor inhibitors: A substitute antiplatelet regimen for aspirin-intolerant patients undergoing percutaneous coronary stent implantation.
    Clin Cardiol. 2022 Feb 4. doi: 10.1002/clc.23787.
    PubMed     Abstract available


  147. KATIKIREDDY CK, Samim A
    Myocardial viability assessment and utility in contemporary management of ischemic cardiomyopathy.
    Clin Cardiol. 2022;45:152-161.
    PubMed     Abstract available


    January 2022
  148. XU J, Chen X, Xie Y, Lin J, et al
    Improvement of cardiac function after coronary artery bypass grafting surgery reduces the risk of postoperative acute kidney injury.
    Clin Cardiol. 2022 Jan 30. doi: 10.1002/clc.23785.
    PubMed     Abstract available


  149. LIN XL, Sun HX, Li FQ, Zhao JY, et al
    Admission high-sensitivity C-reactive protein levels improve the Grace risk score prediction on in-hospital outcomes in acute myocardial infarction patients.
    Clin Cardiol. 2022 Jan 23. doi: 10.1002/clc.23749.
    PubMed     Abstract available


  150. SANG DS, Zhang Q, Song D, Tao J, et al
    Association between brachial-ankle pulse wave velocity and cardiovascular and cerebrovascular disease in different age groups.
    Clin Cardiol. 2022 Jan 23. doi: 10.1002/clc.23777.
    PubMed     Abstract available


  151. YANG L, Zhu H, Sun Y, Yan P, et al
    Value of M2BP in predicting in-stent restenosis in patients after coronary drug-eluting stent implantation.
    Clin Cardiol. 2022 Jan 15. doi: 10.1002/clc.23775.
    PubMed     Abstract available


  152. CHI G, Lee JJ, Kazmi SHA, Fitzgerald C, et al
    Early and late recurrent cardiovascular events among high-risk patients with an acute coronary syndrome: Meta-analysis of phase III studies and implications on trial design.
    Clin Cardiol. 2022 Jan 12. doi: 10.1002/clc.23773.
    PubMed     Abstract available


  153. QIN Q, Chen L, Ge L, Qian J, et al
    A comparison of long-term clinical outcomes between percutaneous coronary intervention (PCI) and medical therapy in patients with chronic total occlusion in noninfarct-related artery after PCI of acute myocardial infarction.
    Clin Cardiol. 2022 Jan 6. doi: 10.1002/clc.23771.
    PubMed     Abstract available


  154. SHI Y, He S, Luo J, Jian W, et al
    Lesion characteristics and procedural complications of chronic total occlusion percutaneous coronary intervention in patients with prior bypass surgery: A meta-analysis.
    Clin Cardiol. 2022 Jan 6. doi: 10.1002/clc.23766.
    PubMed     Abstract available


    December 2021
  155. ZHANG M, Zuo HJ, Yang HX, Nan N, et al
    Trends in conventional cardiovascular risk factors and myocardial infarction subtypes among young Chinese men with a first acute myocardial infarction.
    Clin Cardiol. 2021 Dec 28. doi: 10.1002/clc.23770.
    PubMed     Abstract available


  156. DALLI PEYDRO E, Sanz Sevilla N, Tuzon Segarra MT, Miro Palau V, et al
    A randomized controlled clinical trial of cardiac telerehabilitation with a prolonged mobile care monitoring strategy after an acute coronary syndrome.
    Clin Cardiol. 2021 Dec 24. doi: 10.1002/clc.23757.
    PubMed     Abstract available


    November 2021
  157. DISSANAYAKE HU, Colpani JT, Sutherland K, Loke W, et al
    Obstructive sleep apnea therapy for cardiovascular risk reduction-Time for a rethink?
    Clin Cardiol. 2021 Nov 17. doi: 10.1002/clc.23747.
    PubMed     Abstract available


  158. XING Z, Wang X, Pei J, Zhu Z, et al
    The association of interferon-alpha with development of collateral circulation after artery occlusion.
    Clin Cardiol. 2021;44:1621-1627.
    PubMed     Abstract available


    October 2021
  159. DIAO K, Wang D, Chen Z, Wu X, et al
    Rationale and design of a multi-center, prospective randomized controlled trial on the effects of sacubitril-valsartan versus enalapril on left ventricular remodeling in ST-elevation myocardial infarction: The PERI-STEMI study.
    Clin Cardiol. 2021 Oct 20. doi: 10.1002/clc.23744.
    PubMed     Abstract available


  160. HOFER F, Kazem N, Schweitzer R, Horvat P, et al
    The prognostic impact of left ventricular thrombus resolution after acute coronary syndrome and risk modulation via antithrombotic treatment strategies.
    Clin Cardiol. 2021 Oct 19. doi: 10.1002/clc.23741.
    PubMed     Abstract available


  161. GONG Y, Li X, Ma X, Yu H, et al
    Lipid goal attainment in post-acute coronary syndrome patients in China: Results from the 6-month real-world dyslipidemia international study II.
    Clin Cardiol. 2021 Oct 15. doi: 10.1002/clc.23725.
    PubMed     Abstract available


  162. MOHAMED A
    Predicting mortality and no-reflow in STEMI patients using epicardial adipose tissue.
    Clin Cardiol. 2021;44:1371-1376.
    PubMed     Abstract available


    September 2021
  163. LIMPIJANKIT T, Vathesatogkit P, Matchariyakul D, Yingchoncharoen T, et al
    Cardio-ankle vascular index as a predictor of major adverse cardiovascular events in metabolic syndrome patients.
    Clin Cardiol. 2021 Sep 29. doi: 10.1002/clc.23735.
    PubMed     Abstract available


  164. CHEN G, Farris MS, Cowling T, Pinto L, et al
    Prevalence of atherosclerotic cardiovascular disease and subsequent major adverse cardiovascular events in Alberta, Canada: A real-world evidence study.
    Clin Cardiol. 2021 Sep 29. doi: 10.1002/clc.23732.
    PubMed     Abstract available


    August 2021
  165. KIM YK, Jang CW, Kwon SH, Kim JH, et al
    Ten-year clinical outcomes in patients with intermediate coronary stenosis according to the combined culprit lesion.
    Clin Cardiol. 2021;44:1161-1168.
    PubMed     Abstract available


    July 2021
  166. TANG J, Hou H, Chu J, Chen F, et al
    Clinical implication of quantitative flow ratio to predict clinical events after drug-coated balloon angioplasty in patients with in-stent restenosis.
    Clin Cardiol. 2021;44:978-986.
    PubMed     Abstract available


    May 2021
  167. ECCLESTON DS, Kim JM, Ten Berg JM, Steg PG, et al
    The effect of sex on the efficacy and safety of dual antithrombotic therapy with dabigatran versus triple therapy with warfarin after PCI in patients with atrial fibrillation (a RE-DUAL PCI subgroup analysis and comparison to other dual antithrombotic
    Clin Cardiol. 2021 May 27. doi: 10.1002/clc.23649.
    PubMed     Abstract available


    March 2021
  168. NARANG N, Dela Cruz M, Imamura T, Chung B, et al
    Discordance between lactic acidemia and hemodynamics in patients with advanced heart failure.
    Clin Cardiol. 2021 Mar 18. doi: 10.1002/clc.23584.
    PubMed     Abstract available


  169. KONIGSTEIN M, Ponticelli F, Zivelonghi C, Merdler I, et al
    Long-term outcomes of patients undergoing coronary sinus reducer implantation - A multicenter study.
    Clin Cardiol. 2021;44:424-428.
    PubMed     Abstract available


    February 2021
  170. HUANG W, Lim LMH, Aurangzeb AS, Wong CJ, et al
    Performance of the coronary calcium score in an outpatient chest pain clinic and strategies for risk stratification.
    Clin Cardiol. 2021;44:267-275.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Ischemic Heart Disease is free of charge.